Using thallium-201 SPECT to detect recurrent or residual nasopharyngeal carcinoma after radiotherapy in patients with indeterminate CT findings

Head Neck. 2003 Aug;25(8):645-8. doi: 10.1002/hed.10286.

Abstract

Background: The aim of this study is to evaluate the usefulness of thallium-201 (Tl-201) single-photon emission CT (SPECT) to detect recurrent or residual nasopharyngeal carcinomas (NPC) when CT findings are indeterminate.

Methods: After radiotherapy, 30 NPC patients with indeterminate CT findings were included. CT, Tl-201, and biopsy were performed at least 4 months after radiotherapy and within 1 week of each other. The final results were based on histopathologic findings and clinical follow-up after at least 6 months.

Results: The rates for sensitivity, specificity, and accuracy of Tl-201 SPECT in detecting recurrent or residual NPC when there were indeterminate CT findings, were 86.7%, 93.3%, and 90.0%, respectively.

Conclusions: These results suggest that Tl-201 SPECT is effective in detecting recurrent or residual NPC when CT findings are indeterminate.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Carcinoma / diagnostic imaging
  • Carcinoma / radiotherapy*
  • False Negative Reactions
  • False Positive Reactions
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms / diagnostic imaging
  • Nasopharyngeal Neoplasms / radiotherapy*
  • Neoplasm Recurrence, Local / diagnostic imaging*
  • Neoplasm, Residual / diagnostic imaging
  • Radiopharmaceuticals*
  • Sensitivity and Specificity
  • Thallium Radioisotopes*
  • Tomography, Emission-Computed, Single-Photon / methods*
  • Tomography, X-Ray Computed

Substances

  • Radiopharmaceuticals
  • Thallium Radioisotopes